1. bookVolume 71 (2021): Issue 3 (September 2021)
Journal Details
License
Format
Journal
First Published
25 Mar 2014
Publication timeframe
4 times per year
Languages
English
access type Open Access

Osteoprotective Effects of ‘Anti-Diabetic’ Polyherbal Mixture in Type 1 Diabetic Rats

Published Online: 27 Sep 2021
Page range: 256 - 272
Accepted: 26 Jul 2021
Journal Details
License
Format
Journal
First Published
25 Mar 2014
Publication timeframe
4 times per year
Languages
English
Abstract

Bone loss leading to osteopenia and osteoporosis is a frequent secondary complication of diabetes. This study aimed to evaluate the value of a traditionally used ‘anti-diabetic’ polyherbal mixture as a possible remedy for the prevention of this complication. Diabetes was induced in Wistar female rats with a single intraperitoneal injection of alloxan monohydrate. The animals with blood glucose higher than 20 mmol/L for 14 consecutive days were considered diabetic. For the next 14 days, animals were treated with two concentrations of the polyherbal mixture (10 and 20 g of dry plant material/ kg). Bone histopathology was evaluated using the H&E and Masson’s trichrome staining. Alloxan-induced diabetes triggered bone histological changes characteristic for the development of osteopenia and osteoporosis and treatment with the polyherbal decoction restored these histopathological changes of the bones to the healthy animal level. At the same time, treatment with these tested doses has shown no adverse effects. These findings suggest that this mixture might be used as a remedy for the prevention of diabetic bone loss.

Keywords

1. Bucala R, Vlassara H: Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 1995, 26(6):875-888. Search in Google Scholar

2. Wang J, Wang H: Oxidative stress in pancreatic beta cell regeneration. Oxid Med Cell Longev 2017, 2017:1930261. Search in Google Scholar

3. International Diabetes Federation: IDF Diabetes Atlas, 9th edn. Brussels, Belgium: International Diabetes Federation 2019. http://www.diabetesatlas.org Search in Google Scholar

4. Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM, Luo SQ: Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κB. Biochem Biophys Res Commun 2004, 314:197–207. Search in Google Scholar

5. King GL, Loeken MR: Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 2004. 22:333–338. Search in Google Scholar

6. Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R, Pischon N, Trackman PC, Gerstenfeld L, Graves DT: Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone 2007, 40:345–353. Search in Google Scholar

7. Hamada Y, Kitazawa S, Kitazawa R, Fujii H, Kasuga M, Fukagawa M: Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: A possible role of oxidative stress. Bone 2007, 40:1408–1414. Search in Google Scholar

8. Sanguineti R, Storace D, Monacelli F, Federici A, Odetti P: Pentosidine effects on human osteoblasts in vitro, in: Annals of the New York Academy of Sciences Blackwell Publishing Inc 2008, 1126(1):166–172. Search in Google Scholar

9. Abbassy MA, Watari I, Soma K: The effect of diabetes mellitus on rat mandibular bone formation and microarchitecture. Eur J Oral Sci 2010, 118:364–369. Search in Google Scholar

10. Zhen D, Chen Y, Tang X: Metformin reverses the deleterious effects of high glucose on osteoblast function. J Diabetes Complications 2010, 24:334–344. Search in Google Scholar

11. Okazaki K, Yamaguchi T, Tanaka KI, Notsu M, Ogawa N, Yano S, Sugimoto T: Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis. Calcif Tissue Int 2012, 91:286–296. Search in Google Scholar

12. Zheng W, Wang S, Wang J, Jin F: Periodontitis promotes the proliferation and suppresses the differentiation potential of human periodontal ligament stem cells. Int J Mol Med 2015, 36:915–922. Search in Google Scholar

13. Lebovitz HE:Diagnosis, classification, and pathogenesis of diabetes mellitus. J Clin Psychiatry 2001, 62:5–9. Search in Google Scholar

14. Inzerillo AM, Epstein S:. Osteoporosis and diabetes mellitus. Rev Endocr Metab Disord 2004, 5:261–268. Search in Google Scholar

15. Duarte, V.M.G., Ramos, A.M.O., Rezende, L.A., Macedo, U.B.O., Brandão-Neto, J., Almeida, M.G., Rezende, A.A., 2005. Osteopenia: A bone disorder associated with diabetes mellitus. J Bone Miner Metab 23, 58–68. Search in Google Scholar

16. Silva MJ, Brodt MD, Lynch MA, McKenzie JA, Tanouye KM, Nyman JS, Wang X: Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. J Bone Miner Res 2009, 24:1618–1627. Search in Google Scholar

17. Herskind AM, Christensen K, Nørgaard-Andersen K, Andersen JF: Diabetes mellitus and healing of closed fractures. Diab Metab 1992, 18:63–64. Search in Google Scholar

18. Forsén L, Meyer HE, Midthjell K, Edna TH: Diabetes mellitus and the incidence of hip fracture: Results from the Nord-Trondelag health survey. Diabetologia 1999, 42:920–925. Search in Google Scholar

19. Vestergaard P, Rejnmark L, Mosekilde L: Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int 2009, 84:45–55. Search in Google Scholar

20. Vestergaard P: Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - A meta-analysis. Osteoporos Int 2007, 18:427–444. Search in Google Scholar

21. Hampson G, Evans C, Petitt RJ, Evans WD, Woodhead SJ, Peters JR, Ralston SH: Bone mineral density, collagen type 1 α 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia 1998, 41:1314–1320. Search in Google Scholar

22. López-Ibarra P-J, Pastor MMC, Escobar-Jiménez F, Pardo MDS, González AG, Luna JDD, González AG, Requena MER, Diosdado MA:. Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocr Pract 2001,. 7:346–351. Search in Google Scholar

23. Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T: Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care 2008, 31:1729–1735. Search in Google Scholar

24. Kristin K, Nicodemus BA, Aaron R, Folsom MD: Type 1 and Type 2 Diabetes and Incident Hip Fractures in Postmenopausal Women. Epidemiology 2001, 24:1192–1197. Search in Google Scholar

25. Lim DW, Kim YT: Anti-osteoporotic effects of Angelica sinensis (Oliv.) Diels extract on ovariectomized rats and its oral toxicity in rats. Nutrients 2014, 6(10): 4362–4372. Search in Google Scholar

26. Parasuraman S, Thing GS, Dhanaraj SA: Polyherbal formulation: Concept of ayurveda. Pharmacogn Rev 2014, 8(16):73-80. Search in Google Scholar

27. Han X, Yang Y, Metwaly AM, Xue Y, Shi Y, Dou D: The Chinese herbal formulae (Yitangkang) exerts an antidiabetic effect through the regulation of substance metabolism and energy metabolism in type 2 diabetic rats. J Ethnopharmacol 2019, 239:111942. Search in Google Scholar

28. Künzle J: Herbs and weeds: A practical booklet on medicinal herbs Switzerland 1911. Search in Google Scholar

29. Madić V, Stojanović-Radić Z, Jušković M, Jugović D, Žabar-Popović A, Vasiljević P:. Genotoxic and antigenotoxic potential of herbal mixture and five medicinal plants used in ethnopharmacology. South African J Bot 2019, 125:290–297. Search in Google Scholar

30. Madić V, Petrović A, Jušković M, Jugović D, Djordjević Lj, Stojanović G, Vasiljević P: Polyherbal mixture ameliorates hyperglycemia, hyperlipidemia and histopathological changes of pancreas, kidney and liver in a rat model of type 1 diabetes. J Ethnopharmacol 2021, 265:113210. Search in Google Scholar

31. Liang W, Luo Z, Ge S, Li M, Du J, Yang M, Yan M, Ye Z, Luo Z: Oral administration of quercetin inhibits bone loss in rat model of diabetic osteopenia. Eur J Pharmacol 2011, 670:317–324. Search in Google Scholar

32. Abu Ayana MA, Elmasry NA, Shehata FI, Khalil NM: Efficiacy of quercetin on alveolar bone structure of rats with induced diabetes. Alexandria Dent J 2017, 42:141–146. Search in Google Scholar

33. Banda M, Nyirenda J, Muzandu K, Sijumbila G, Mudenda S: Antihyperglycemic and Antihyperlipidemic Effects of Aqueous Extracts of Lannea edulis in Alloxan-Induced Diabetic Rats. Front Pharmacol 2018, 9-1099. Search in Google Scholar

34. Ay B, Parolia K, Liddell RS, Qiu Y, Grasselli G, Cooper DML, Davis JE: Hyperglycemia compromises Rat Cortical Bone by Increasing Osteocyte Lacunar Density and Decreasing Vascular Canal Volume. Commun Biol 2020, 3:20. Search in Google Scholar

35. Mullender MG, Van Der Meer DD, Huiskes R, Lips P: Osteocyte density changes in aging and osteoporosis. Bone 1996, 18:109–113. Search in Google Scholar

36. Leite Duarte ME, da Silva RD: Histomorphometric analysis of the bone tissue in patients with non-insulin-dependent diabetes (DMNID). Rev Hosp Clin Fac Med 1996, 51:7–11. Search in Google Scholar

37. Vashishth D, Gibson G, Kimura J, Schaffler MB, Fyhrie DP: Determination of bone volume by osteocyte population. Anat. Rec 2002, 267:292–295. Search in Google Scholar

38. He Y, Mu C, Shen X, Yuan Z, Liu J, Chen W, Lin C, Tao B, Liu B, Cai K:Peptide LL-37 coating on micro-structured titanium implants to facilitate bone formation in vivo via mesenchymal stem cell recruitment. Acta Biomater 2018, 80:412-424. Search in Google Scholar

39. Tuukkanen J, Koivukangas A, Jämsä T, Sundquist K, MacKay CA, Marks SC: Mineral Density and Bone Strength Are Dissociated in Long Bones of Rat Osteopetrotic Mutations. J Bone Miner Res 2000, 15:1905–1911. Search in Google Scholar

40. Chauhan S, Sharma A, Upadhyay NK, Singh G, Lal UR, Goyal R: In-vitro osteoblast proliferation and in-vivo anti-osteoporotic activity of Bombax ceiba with quantification of Lupeol, gallic acid and β-sitosterol by HPTLC and HPLC. BMC Complement Altern Med 2018:18. Search in Google Scholar

41. Domazetovic V, Marcucci G, Pierucci F, Bruno G, Di Cesare Mannelli L, Ghelardini C, Brandi ML, Iantomasi T, Meacci E, Vincenzini MT: Blueberry juice protects osteocytes and bone precursor cells against oxidative stress partly through SIRT1. FEBS Open Bio 2019, 9:1082–1096. Search in Google Scholar

42. Zeiger E: Illusions of safety: antimutagens can be mutagens, and anticarcinogens can be carcinogens. Mutat Res / Reviews in Mutat Res 2003, 543:191–194. Search in Google Scholar

43. Mody N, Parhami F, Sarafian TA, Demer LL: Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001, 31:509–519. Search in Google Scholar

44. El-Tantawy WH, Al Haleem ENA: Therapeutic effects of stem cell on hyperglycemia, hyperlipidemia, and oxidative stress in alloxan-treated rats. Mol Cell Biochem. 2014, 391:193-200. Search in Google Scholar

45. Fowlkes JL, Bunn RC, Thrailkill KM. Contributions of the insulin/insulin-like growth factor-1 axis to diabetic osteopathy. J Diabetes Metab. 2011, 1(3):S1-003. Search in Google Scholar

46. Tsentidis C, Gourgiotis D, Kossiva L, et al. Higher levels of s- RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis. Osteoporos Int. 2016; 27:1631-1643. Search in Google Scholar

47. Shah VN, Harrall KK, Shah CS, et al. Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature. Osteoporos Int. 2017, 28:2601-2610. Search in Google Scholar

48. Yano H, Ohya K, Amagasa T: Effects of Insulin on in vitro bone formation in fetal rat parietal bone. Endocr J. 1994, 41:293-300. Search in Google Scholar

49. Cortizo AM, Sedlinsky C, McCarthy D, Blanco A, Schurman L: Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. Eur J Pharmacol. 2006, 536:38-46 Search in Google Scholar

50. Mai QG, Zhang ZM, Xu S, et al. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. J Cell Biochem. 2011, 112:2902-2909. Search in Google Scholar

51. Gao Y, Li Y, Xue J, Jia Y, Hu J: Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats. Eur J Pharmacol. 2010, 635:231-263. Search in Google Scholar

52. Behera HN, Patnaik BK: Recovery from alloxan diabetes as revealed by collagen characteristics of bone, skin and tendon of Swiss Mice. Gerontology 1981, 27:32-36. Search in Google Scholar

53. Villarino ME, Sánchez LM, Bozal CB, Ubios AM: Influence of short-term diabetes on osteocytic lacunae of alveolar bone. A histomorphometric study. Acta Odontol Latinoam 2006, 19:23–28. Search in Google Scholar

54. Molinuevo MS, Schurman L, McCarthy AD, Cortizo AM, Tolosa MJ, Gangoiti MV, Arnol V, Sedlinsky C: Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies. J J Bone Miner Res 2010, 25: 211-221. Search in Google Scholar

55. Spanheimer RG, Umpierrez GE, Stumpf V: Decreased collagen production in diabetic rats. Diabetes 1988, 37:371–376. Search in Google Scholar

56. Pulido R, Bravo L, Saura-Calixto F: Antioxidant activity of dietary polyphenols as determined by a modified ferric reducing/antioxidant power assay. J Agric Food Chem 2000, 48:3396–3402. Search in Google Scholar

57. Takebayashi J, Ishii R, Chen J, Matsumoto T, Ishimi Y, Tai A: Reassessment of antioxidant activity of arbutin: Multifaceted evaluation using five antioxidant assay systems. Free Radic. Res 2010, 44:473–478. Search in Google Scholar

58. Jeszka-Skowron M, Krawczyk M, Zgoła-Grześkowiak A: Determination of antioxidant activity, rutin, quercetin, phenolic acids and trace elements in tea infusions: Influence of citric acid addition on extraction of metals. J Food Compos Anal 2015, 40:70-77. Search in Google Scholar

59. Frei B, Higdon JV: Antioxidant Activity of Tea Polyphenols In Vivo: Evidence from Animal Studies. J Nutr 2003, 133(10):3275S-3284S. Search in Google Scholar

60. Oka Y, Iwai S, Amano H, Irie Y, Yatomi K, Ryu K, Yamada S, Inagaki K, Oguchi K: Tea Polyphenols Inhibit Rat Osteoclast Formation and Differentiation. J Pharmacol Sci 2011, 118(1):55-64. Search in Google Scholar

61. Hasan W, Ahmad S, Thakur H, Abbas M: In vitro regulation of osteoclast generation: a cost-effective strategy to combat osteoporosis with natural antioxidants and polyphenols like EGCG. Eur J Acad Res 2014, 2:2286-4822. Search in Google Scholar

62. Nicolin, V., De Tommasi, N., Nori, S.L., Costantinides, F., Berton, F., Di Lenarda, R., 2019. Modulatory Effects of Plant Polyphenols on Bone Remodeling: A Prospective View From the Bench to Bedside. Front Endocrinol (Lausanne). 10, 494. Search in Google Scholar

63. Jayachandrana M, Wua Z, Ganesana K, Khalidb S, Chunga SM, Xua B: Isoquercetin upregulates antioxidant genes, suppresses inflammatory cytokines and regulates AMPK pathway in streptozotocin-induced diabetic rats. Chem-Biol Interact 2019, 303:62-69. Search in Google Scholar

64. Kyung TW, Lee JE, Shin HH, Choi HS: Rutin inhibits osteoclast formation by decreasing reactive oxygen species and TNF-α by inhibiting activation of NF-κB. Exp Mol Med 2008, 40:52–58. Search in Google Scholar

65. Fayeda HA, Barakata BM, Elshaerb SS, Abdel-Naimc AB, Menzed ET: Antiosteoporotic activities of isoquercitrin in ovariectomized rats: Role of inhibiting hypoxia inducible factor-1 alpha. Eur J Pharmacol 2019, 865: 172785. Search in Google Scholar

66. Horcajada-Molteni MN, Crespy V, Coxam V, Davicco MJ, Rémésy C, Barlet JP: Rutin Inhibits Ovariectomy-Induced Osteopenia in Rats. JBMR 2000, 15:2251-2258. Search in Google Scholar

67. Yokoyama A, Sakakibara H, Crozier A, Kawai Y, Matsui A, Terao J, Kumazawa S, Shimoi K: Quercetin metabolites and protection against peroxynitrite-induced oxidative hepatic injury in rats. Free Radic Res 2009, 43:913-21. Search in Google Scholar

68. Man X, Yang L, Liu S, Yang L, Li M, Fu Q: Arbutin promotes MC3T3-E1 mouse osteoblast precursor cell proliferation and differentiation via the Wnt/ß-catenin signaling pathway. Mol Med Rep 2019, 19:4637–4644. Search in Google Scholar

69. Prouillet C, Mazière J-C, Mazière C, Wattel A, Brazier M, Kamel S: Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol 2004, 67:1307–1313. Search in Google Scholar

70. Kanter M, Altan MF, Donmez S, Ocakci A, Kartal ME: The effects of quercetin on bone minerals, biomechanical behavior, and structure in streptozotocin-induced diabetic rats. Cell Biochem Funct 2007, 25:747–752. Search in Google Scholar

71. Derakhshanian H, Ghadbeigi S, Rezaian M, Bahremand A, Javanbakht MH, Golpaie A, Hosseinzadeh P, Tajik N, Dehpour AR: Quercetin improves bone strength in experimental biliary cirrhosis. Hepatol Res 2013, 43:394–400. Search in Google Scholar

72. Omori A, Yoshimura Y, Deyama Y, Suzuki K: Rosmarinic acid and arbutin suppress osteoclast differentiation by inhibiting superoxide and NFATc1 downregulation in RAW 264.7 cells. Biomed Reports 2015, 3:483–490. Search in Google Scholar

73. Barhoma RA, Hegab II, Atef MM, El-Shamy AM: Unraveling the Role of Melatonin/ Quercetin in Attenuating the Metabolic and Bone Turnover Alternations in Iron Treated-Ovariectomized Female Rats. Med J Cairo Univ 2019, 87:2857-2870. Search in Google Scholar

74. Chen Y, Dai F, He Y, Chen Q, Xia Q, Cheng G, Lu Y, Zhang Q: Beneficial effects of hyperoside on bone metabolism in ovariectomized mice. Biomed Pharmacother 2018, 107:1175–1182. Search in Google Scholar

75. Qi X-C, Li B, Wu W-L, Liu, H-C, Jiang Y-P: Protective effect of hyperoside against hydrogen peroxide-induced dysfunction and oxidative stress in osteoblastic MC3T3-E1 cells. Artif Cells Nanomedicine Biotechnol 2020. 48, 377–383. Search in Google Scholar

76. Liu L, Wang D, Qin Y, Xu M, Zhou L, Xu W, Liu X, Ye L, Yue S, Zheng Q, Li D: Astragalin Promotes Osteoblastic Differentiation in MC3T3-E1 Cells and Bone Formation in vivo. Front Endocrinol (Lausanne) 2019, 10:228. Search in Google Scholar

77. Karadeniz F, Oh JH, Lee JI, Seo Y, Kong CS: 3,5-dicaffeoyl-epi-quinic acid from Atriplex gmelinii enhances the osteoblast differentiation of bone marrow-derived human mesenchymal stromal cells via WnT/BMP signaling and suppresses adipocyte differentiation via AMPK activation. Phytomedicine 2020, 71:153225. Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo